EFFECTS ON HEALTH AND COSTS OF DELAYED IMPLEMENTATION OF THE ONCOTYPE DX® TEST FOR ELIGIBLE BREAST CANCER PATIENTS

被引：0
|
作者：
Appelberg, K. [1 ]
Wilking, N. [2 ]
Levin, L. A. [1 ]
机构：
[1] Linkoping Univ, Linkoping, Sweden
[2] Karolinska Inst, Solna, Sweden
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE93
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [41] Cost effectiveness of oncotype Dx for early stage breast cancer under National health insurance
    Kim, Yumi
    Han, Wonshik
    CANCER RESEARCH, 2018, 78 (04)
  • [42] Discordance in Oncotype DX Breast Recurrence Score® Results for Bilateral Breast Cancer
    Joshua A. Bloom
    Yurie Sekigami
    Rebekah Young
    Lisa Macera
    Christy A. Russell
    Yu Cao
    Rachel J. Buchsbaum
    Stephen P. Naber
    Abhishek Chatterjee
    Annals of Surgical Oncology, 2021, 28 : 8711 - 8716
  • [43] Discordance in Oncotype DX Breast Recurrence Score Results for Bilateral Breast Cancer
    Bloom, J. A.
    Sekigami, Y.
    Cao, Y.
    Buchsbaum, R. J.
    Naber, S. P.
    Chatterjee, A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S51 - S51
  • [44] Is the oncotype DX test useful in elderly breast cancer patients: a subgroup analysis of real-life Italian PONDx study
    Barni, Sandro
    Cognetti, Francesco
    Petrelli, Fausto
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (02) : 477 - 480
  • [45] Is the oncotype DX test useful in elderly breast cancer patients: a subgroup analysis of real-life Italian PONDx study
    Sandro Barni
    Francesco Cognetti
    Fausto Petrelli
    Breast Cancer Research and Treatment, 2022, 191 : 477 - 480
  • [46] Implementing gene expression profiling test (MammaPrint and Oncotype DX) in daily breast cancer pratice in the Netherlands
    Scholten, M.
    Gaal, R.
    BREAST, 2025, 80
  • [47] Cost effectiveness analysis of Oncotype DX testing in patients with synchronous unilateral primary breast cancer
    Clark, Melanie Jean
    Coggan, James
    Dignam, James J.
    Rao, Ruta D.
    Usha, Lydia
    Kabaker, Katherine
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] Verification of a Western Nomogram for Predicting Oncotype DX™ Recurrence Scores in Korean Patients with Breast Cancer
    Kim, Jae-Myung
    Ryu, Jai Min
    Kim, Isaac
    Choi, Hee Jun
    Nam, Seok Jin
    Kim, Seok Won
    Yu, Jonghan
    Lee, Se Kyung
    Lee, Jeong Eon
    JOURNAL OF BREAST CANCER, 2018, 21 (02) : 222 - 226
  • [49] Age's importance in early breast cancer: Oncotype Dx results in patients ≤40 years
    Ruiz, R.
    Namuche, F.
    Morante, Z.
    Aguilar, A.
    Urrunaga, D.
    Ziegler, G.
    Chavez Mac Gregor, M.
    Leon, M.
    Gomez, H.
    CANCER RESEARCH, 2019, 79 (04)
  • [50] Evaluation of Oncotype DX as a predictor of nodal burden in clinically node negative breast cancer patients
    Tevis, Sarah
    Bedrosian, Isabelle
    Bassett, Roland
    FitzSullivan, Elizabeth
    Barcenas, Carlos
    Meric-Bernstam, Funda
    Hunt, Kelly
    Caudle, Abigail
    Kuerer, Henry
    Mittendorf, Elizabeth
    Thompson, Alastair
    Teshome, Mediget
    Lucci, Anthony
    DeSnyder, Sarah
    Black, Shon
    Park, Ko Un
    Hwang, Rosa
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 289 - 289
12345